Roche’s Ocrevus, Novartis’ Kesimpta set to lead CNS market to strongest growth in over a decade: report

Roche’s Ocrevus, Novartis’ Kesimpta set to lead CNS market to strongest growth in over a decade: report

How Roche is Optimising Global Lab Supply Chains With Tecsys

How Roche is Optimising Global Lab Supply Chains With Tecsys

Swiss drugmakers Novartis and Roche ditch some diversity programmes on US concerns

Swiss drugmakers Novartis and Roche ditch some diversity programmes on US concerns